Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Cancer biomarkers : section A of Disease markers |
| Vol/bind | 5 |
| Udgave nummer | 4 |
| Sider (fra-til) | 197-205 |
| Antal sider | 8 |
| DOI | |
| Status | Udgivet - 2009 |
Adgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Familial colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? - A case-control study. / Sunde, Lone; Bisgaard, Marie Luise; Soll-Johanning, Helle; Jacobsen, Niels Otto; Bolund, Lars; Skouv, Jan; Lynge, Elsebeth.
I: Cancer biomarkers : section A of Disease markers, Bind 5, Nr. 4, 2009, s. 197-205.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › peer review
}
TY - JOUR
T1 - Familial colorectal cancer, can it be identified by microsatellite instability and chromosomal instability? - A case-control study
AU - Sunde, Lone
AU - Bisgaard, Marie Luise
AU - Soll-Johanning, Helle
AU - Jacobsen, Niels Otto
AU - Bolund, Lars
AU - Skouv, Jan
AU - Lynge, Elsebeth
PY - 2009
Y1 - 2009
N2 - Colonoscopy is recommended for persons with a familial risk of colorectal cancer (CRC). A familial risk is identified by a family history with CRC and/or predisposing mutation(s). However, such information may not be available. We analysed whether MSI (MicroSatellite Instability) and/or CIN (Chromosome INstability=LOH (loss of heterozygosity) and/or DNA-aneuploidy (abnormal nuclear DNA contents)) could be used as predictors of familial CRC. Formalin-fixed tissue from 97 patients with CRC (29 patients with 2 or more affected first-degree relatives (="cases"), 29 matched CRC controls without a family history, and 39 relatives to cases) were analysed for MSI and CIN. In this small case-control study, no significant differences in the frequencies of MSI and CIN were observed between cases with a family history and their controls without a family history. MSI+;CIN- was observed in 6/29 cases and in 0/29 controls (p=0.02), most frequently in cases with affected siblings, only (3/7). However, for 13 patients from whom several CRC tumours were analysed, concordant results for MSI/LOH/DNA-ploidy were obtained only in 10/9/9. Among cases and relative(s), concordant results for MSI, LOH and DNA-ploidy were obtained in 16/26, 16/26, and 14/25 families, respectively.Although MSI+;CIN- appeared to predict familial CRC with a high specificity, neither MSI, CIN, or MSI+;CIN- are likely to be sufficiently sensitive predictors of familial CRC.
AB - Colonoscopy is recommended for persons with a familial risk of colorectal cancer (CRC). A familial risk is identified by a family history with CRC and/or predisposing mutation(s). However, such information may not be available. We analysed whether MSI (MicroSatellite Instability) and/or CIN (Chromosome INstability=LOH (loss of heterozygosity) and/or DNA-aneuploidy (abnormal nuclear DNA contents)) could be used as predictors of familial CRC. Formalin-fixed tissue from 97 patients with CRC (29 patients with 2 or more affected first-degree relatives (="cases"), 29 matched CRC controls without a family history, and 39 relatives to cases) were analysed for MSI and CIN. In this small case-control study, no significant differences in the frequencies of MSI and CIN were observed between cases with a family history and their controls without a family history. MSI+;CIN- was observed in 6/29 cases and in 0/29 controls (p=0.02), most frequently in cases with affected siblings, only (3/7). However, for 13 patients from whom several CRC tumours were analysed, concordant results for MSI/LOH/DNA-ploidy were obtained only in 10/9/9. Among cases and relative(s), concordant results for MSI, LOH and DNA-ploidy were obtained in 16/26, 16/26, and 14/25 families, respectively.Although MSI+;CIN- appeared to predict familial CRC with a high specificity, neither MSI, CIN, or MSI+;CIN- are likely to be sufficiently sensitive predictors of familial CRC.
U2 - 10.3233/CBM-2009-0104
DO - 10.3233/CBM-2009-0104
M3 - Journal article
C2 - 19729829
VL - 5
SP - 197
EP - 205
JO - Cancer Biomarkers
JF - Cancer Biomarkers
SN - 1574-0153
IS - 4
ER -